Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

A.m. Pappas & Associates

BioCentury | Mar 16, 2015
Finance

Aura finds the right mix

Why VCs thought the time was right to invest in Aura's nanoparticle story
BioCentury | Mar 6, 2015
Financial News

Aura Biosciences raises $21M series B

BioCentury | Sep 8, 2014
Finance

Chiesi expands rare disease universe

Why Chiesi launched strategic venture fund for rare diseases with Pappas
BioCentury | Feb 15, 2010
Finance

Anthera's test

BioCentury | Dec 21, 2009
Finance

Ebb & Flow

BioCentury | Dec 18, 2006
Finance

Ebb & Flow

BioCentury | Nov 30, 2005
Financial News

CeNeRx raises $18.5 million

BioCentury | Sep 19, 2005
Finance

Ebb & Flow

BioCentury | Aug 29, 2005
Finance

Ebb & Flow

BioCentury | Aug 24, 2005
Top Story

Cerexa raises $50 million

Items per page:
1 - 10 of 54